| Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein M Bentham, S Mazaleyrat, M Harris Journal of general virology 87 (3), 563-571, 2006 | 145 | 2006 |
| Cytoplasmic functions of TDP-43 and FUS and their role in ALS N Birsa, MP Bentham, P Fratta Seminars in cell & developmental biology 99, 193-201, 2020 | 109 | 2020 |
| Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel TL Foster, M Verow, AL Wozniak, MJ Bentham, J Thompson, E Atkins, ... Hepatology 54 (1), 79-90, 2011 | 87 | 2011 |
| Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer A Samson, MJ Bentham, K Scott, G Nuovo, A Bloy, E Appleton, RA Adair, ... Gut 67 (3), 562-573, 2018 | 73 | 2018 |
| FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention J Humphrey, N Birsa, C Milioto, M McLaughlin, AM Ule, D Robaldo, ... Nucleic acids research 48 (12), 6889-6905, 2020 | 72 | 2020 |
| Structure‐guided design affirms inhibitors of hepatitis C virus p7 as a viable class of antivirals targeting virion release TL Foster, GS Thompson, AP Kalverda, J Kankanala, M Bentham, ... Hepatology 59 (2), 408-422, 2014 | 68 | 2014 |
| Release of Infectious Hepatitis C Virus from Huh7 Cells Occurs via a trans-Golgi Network-to-Endosome Pathway Independent of Very-Low-Density Lipoprotein … J Mankouri, C Walter, H Stewart, M Bentham, WS Park, WD Heo, ... Journal of virology 90 (16), 7159-7170, 2016 | 47 | 2016 |
| The di-leucine motif in the cytoplasmic tail of CD4 is not required for binding to human immunodeficiency virus type 1 Nef, but is critical for CD4 down-modulation M Bentham, S Mazaleyrat, M Harris Journal of general virology 84 (10), 2705-2713, 2003 | 42 | 2003 |
| Mutations in hepatitis C virus p7 reduce both the egress and infectivity of assembled particles via impaired proton channel function MJ Bentham, TL Foster, C McCormick, S Griffin Journal of General Virology 94 (10), 2236-2248, 2013 | 39 | 2013 |
| Formation of Higher-Order Foot-and-Mouth Disease Virus 3Dpol Complexes Is Dependent on Elongation Activity M Bentham, K Holmes, S Forrest, DJ Rowlands, NJ Stonehouse Journal of virology 86 (4), 2371-2374, 2012 | 36 | 2012 |
| Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza C Scott, J Kankanala, TL Foster, DH Goldhill, P Bao, K Simmons, ... PLoS Pathogens 16 (8), e1008716, 2020 | 11 | 2020 |
| TDP-43 mutations increase HNRNP A1-7B through gain of splicing function P Sivakumar, F De Giorgio, AM Ule, J Neeves, RR Nair, M Bentham, ... Brain 141 (12), e83-e83, 2018 | 10 | 2018 |
| FUS ALS-causative mutations impact FUS autoregulation and the processing of RNA-binding proteins through intron retention J Humphrey, N Birsa, C Milioto, D Robaldo, AB Eberle, R Kräuchi, ... BioRxiv, 567735, 2019 | 9 | 2019 |
| Inhibitors of the small membrane (M) protein viroporin prevent zika virus infection E Brown, G Swinscoe, D Lefteri, R Singh, A Moran, R Thompson, ... bioRxiv, 2021.03. 11.435022, 2021 | 5 | 2021 |
| Rationally derived inhibitors of hepatitis C virus (HCV) p7 channel activity reveal prospect for bimodal antiviral therapy J Shaw, R Gosain, MM Kalita, TL Foster, J Kankanala, DR Mahato, ... Elife 9, e52555, 2020 | 5 | 2020 |
| Flavivirus membrane (M) proteins as potential ion channel antiviral targets E Brown, H Beaumont, D Lefteri, M Bentham, R Foster, C McKimmie, ... Access Microbiology 1 (1A), 553, 2019 | 4 | 2019 |
| NS2 is dispensable for efficient assembly of hepatitis C virus-like particles in a bipartite trans-encapsidation system MJ Bentham, N Marraiki, CJ McCormick, DJ Rowlands, S Griffin Journal of General Virology 95 (11), 2427-2441, 2014 | 1 | 2014 |
| The prevention of tympanic membrane perforation following the removal of long‐term Paparella type II ventilation tubes. Clin. Otolaryngol. 12, 377–381 BJG Bingham, E Chevretton Clinical Otolaryngology & Allied Sciences 13 (6), 501-504, 1988 | 1 | 1988 |
| TKI-conditioned immunotherapy using uv-inactivated reovirus promotes survival in hepatocellular carcinoma, mediated by cytotoxic CD4+ T-cells R Hughes, A Moran, KJ Scott, E Appleton, MJ Bentham, E Ilett, A Melcher, ... bioRxiv, 2024.02. 23.581738, 2024 | | 2024 |
| Combined anti-viral and anti-tumour therapy for virus-associated liver cancer A Jebar, M Bentham, F Errington-Mais, K Scott, A Peckham-Cooper, ... HUMAN GENE THERAPY 25 (12), A27-A27, 2014 | | 2014 |
